Search

AKU’s Dr Zulfiqar Bhutta awarded prestigious Virchow Prize 2025

World-renowned global health expert from AKU honored for transformative leadership in maternal, newborn, and child health equity through research and policy

Abid Lodhi 12:34 PM, 16 Jul, 2025
Dr Zulfiqar Bhutta receives Virchow Prize 2025 for global health impact in maternal and child care
Caption: Dr Zulfiqar A. Bhutta of AKU awarded the Virchow Prize 2025 for his leadership in global maternal and child health research and policy. (Photo courtesy of AKU)

Dr Zulfiqar Bhutta receives Virchow Prize 2025 for leadership in global maternal and child health

KARACHI: Dr Zulfiqar A. Bhutta, founding director of the Institute for Global Health and Development at the Aga Khan University (AKU), has been awarded the highly prestigious Virchow Prize 2025. This global honor recognizes his decades-long leadership in advancing maternal, newborn, and child health (MNCH) equity through community-based, evidence-driven research and policy innovation.

Dr Bhutta shares the Virchow Prize 2025 with Professor Quarraisha Abdool Karim of South Africa. The award, presented by the Virchow Foundation, is among the world’s most respected accolades in global health, honoring contributions that align with the United Nations Sustainable Development Goals (SDGs) and the vision of “Health for All.”

Recognizing lifelong commitment to health equity

The Virchow Prize Committee praised Dr Bhutta’s exceptional contributions, citing his relentless commitment to addressing structural inequalities in healthcare. For over four decades, his pioneering research and policy influence have helped reshape the global health architecture, particularly by focusing on low- and middle-income countries (LMICs) and populations historically excluded from mainstream health systems.

You may like: Dr. Zulfiqar Bhutta honored as Officer of the Order of Canada

In their official citation, the committee noted, “Dr Bhutta’s work has been instrumental in shaping global health guidelines and influencing national policies for maternal, child health, and nutrition in low- and middle-income countries. He has championed community-based primary care models, large-scale randomized trials, and implementation research within vulnerable communities and fragile settings.”

Scientific excellence with real-world impact

With over 1,400 scientific publications and advisory roles in top-tier organizations such as WHO, UNICEF, and PMNCH, Dr Bhutta is globally recognized as a thought leader whose research leads directly to life-saving policies. His work has played a pivotal role in reducing maternal and child mortality across South-Central Asia, sub-Saharan Africa, and in humanitarian crises worldwide.

In a statement, Dr Bhutta reflected with humility and gratitude: “This award is a recognition of the ongoing contribution by numerous collaborators, students and trainees who have worked tirelessly to address some of the world’s most challenging problems affecting its women and children; to them I owe a tremendous debt of gratitude for being part of this ongoing journey.”

Pride for Pakistan and AKU

This recognition marks a monumental moment for Aga Khan University and a proud milestone for Pakistan on the global stage. It showcases AKU’s continued commitment to globally relevant, locally rooted health research that responds to the most pressing needs of underserved communities.

Dr Sulaiman Shahabuddin, President of AKU, expressed heartfelt congratulations: “As president of Aga Khan University, it is a personal privilege to congratulate Dr Bhutta on receiving the Virchow Prize 2025 – an honour both profound and richly deserved. His lifelong dedication to improving maternal, newborn, and child health in underserved communities speaks directly to the heart of our mission and reaffirms AKU’s commitment to advancing global health equity and driving meaningful, lasting change.”


Stay informed. Stay ahead.

CLICK HERE TO FOLLOW Medical News Pakistan WhatsApp Channel for trusted healthcare updates, expert insights, clinical research, policy news, and medical breakthroughs—delivered directly to you.